The Hidden Danger in High-Purity Peptides
In pharmaceutical development, a dangerous misconception persists: that high chemical purity guarantees safety. This fallacy has led to research failures, compromised clinical trials, and potentially life-threatening patient exposures. The stark reality is that peptides demonstrating 95% or even 99% chemical purity can simultaneously harbor endotoxin levels that far exceed pharmaceutical safety limits…
The misconception that high chemical purity guarantees safety in pharmaceutical development is dangerous. It can lead to research failures, compromised clinical trials, and life-threatening patient exposures. Peptides with 95% or even 99% purity may still contain endotoxin levels that exceed safety limits.